BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14606406)

  • 1. [Better prognosis for dialysis dependent type 2 diabetic patient. Statin delays arterial onset of arterial stiffness].
    MMW Fortschr Med; 2003 Apr; 145(16):60. PubMed ID: 14606406
    [No Abstract]   [Full Text] [Related]  

  • 2. [Type 2 diabetic: risk same as after infarct. With LDL not only the quantity counts].
    MMW Fortschr Med; 2004 Jun; 146(24):4. PubMed ID: 15366509
    [No Abstract]   [Full Text] [Related]  

  • 3. Who does not need a statin: too late in end-stage renal disease or heart failure?
    Laufs U; Custodis F; Böhm M
    Postgrad Med J; 2009 Apr; 85(1002):187-9. PubMed ID: 19417167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvastatin in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.
    Corsini A; Holdaas H
    Ren Fail; 2005; 27(3):259-73. PubMed ID: 15957541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Are the guidelines correct? Should all patients with coronary heart disease or diabetes be treated with a statin?].
    Pöss J; Böhm M; Laufs U
    Med Klin (Munich); 2009 Jan; 104(1):74-8. PubMed ID: 19142597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does time of onset of therapy alter the protective cardiovascular effect of fluvastatin after renal transplantation?
    Morales JM
    Nat Clin Pract Nephrol; 2005 Dec; 1(2):78-9. PubMed ID: 16932372
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels.
    Katsiki N; Mikhailidis DP; Banach M
    J Hypertens; 2011 Dec; 29(12):2493-4; author reply 2494. PubMed ID: 22075958
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of dyslipidemia in renal disease and transplantation.
    Zolezzi M
    Saudi J Kidney Dis Transpl; 2006 Jun; 17(2):129-36. PubMed ID: 16903617
    [No Abstract]   [Full Text] [Related]  

  • 9. [Not just decreased LDL level is decisive. Which statin for patients at risk for coronary disease?].
    MMW Fortschr Med; 2004 Jun; 146(24):1-3. PubMed ID: 15366507
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of HMG-CoA-reductase inhibitors on survival in type 2 diabetes patients with end stage diabetic nephropathy.
    Götz AK; Böger CA; Hirschmann C; Schmitz G; Riegger GA; Krämer BK
    Eur J Med Res; 2005 Apr; 10(4):155-60. PubMed ID: 15946911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High therapeutic effect and safety of fluvastatin].
    Pharm Unserer Zeit; 2003; 32(6):516-7. PubMed ID: 14639833
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin therapy in renal disease.
    Iglesias P; Díez JJ
    Diabetes Obes Metab; 2008 Sep; 10(10):811-23. PubMed ID: 18248491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Lovastatin for reduction of leptin in nondialysis patients with type 2 diabetic nephropathy.
    Ahmadi F; Mohebi-Nejad A
    Iran J Kidney Dis; 2014 Jul; 8(4):344-5. PubMed ID: 25001144
    [No Abstract]   [Full Text] [Related]  

  • 14. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis.
    Goldfarb-Rumyantzev AS; Habib AN; Baird BC; Barenbaum LL; Cheung AK
    Am J Kidney Dis; 2007 Nov; 50(5):791-802. PubMed ID: 17954292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating dyslipidaemia in the setting of diabetes mellitus and cardiovascular disease: another focus.
    Tahrani AA
    Int J Clin Pract; 2006 Nov; 60(11):1515; author reply 1515-6. PubMed ID: 17073848
    [No Abstract]   [Full Text] [Related]  

  • 16. [Type 2 diabetic patient with kidney damage. Sartans banish dialysis risk].
    MMW Fortschr Med; 2004 Jul; 146(27-28):56. PubMed ID: 15526676
    [No Abstract]   [Full Text] [Related]  

  • 17. Lessons learnt from the 4D trial.
    Wanner C; Krane V
    Nephrol Ther; 2006 Feb; 2(1):3-7. PubMed ID: 16895709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does statin therapy improve cardiovascular outcomes in patients with type 2 diabetes receiving hemodialysis?
    Kwan BC; Beddhu S; Kronenberg F; Cheung AK
    Nat Clin Pract Nephrol; 2006 Feb; 2(2):76-7. PubMed ID: 16932397
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.
    Dogra G; Irish A; Chan D; Watts G
    Am J Kidney Dis; 2007 Jun; 49(6):776-85. PubMed ID: 17533020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of statins on arterial pressure and stiffness of hypertensives.
    Ichihara A; Hayashi M; Koura Y; Tada Y; Kaneshiro Y; Saruta T
    J Hum Hypertens; 2005 Feb; 19(2):103-9. PubMed ID: 15361892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.